Work

88: Outcome after Autologous Stem Cell Transplantation for Multiple Myeloma in Patients with Preceeding Plasma Cell Disorders

Year: 2008

Type: article

Abstract: Background: Nearly a third of patients with newly diagnosed myeloma (MM) have a preceding diagnosis of plasma cell proliferative disorder (PCPD), mostly monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM) or plasmacytoma. While high dose therapy improves survival in patients with myeloma, it is not clear if patients with preceding PCPD have a different outcome. Methods and Results: We identified 151 patients with preceding PCPD from among 804 patients undergoing high dose therapy at our institution.

Source: Transplantation and Cellular Therapy

DOI: 10.1016/j.bbmt.2007.12.097